Literature DB >> 19579092

Treatment entry among individuals on a waiting list for methadone maintenance.

Jan Gryczynski1, Robert Schwartz, Kevin O'Grady, Jerome Jaffe.   

Abstract

BACKGROUND: Many methadone programs in the United States have waiting lists for care.
OBJECTIVES: To examine specific predictors of treatment entry among individuals on a waiting list for methadone maintenance.
METHODS: Heroin users placed on a waiting list for methadone treatment (n = 120) were administered a urine screen for drug use and assessed with a battery of measures at study entry and at 4 month follow-up as part of a larger clinical trial. Logistic regression was used to examine hypothesized predictors of treatment entry. Outcomes for those failing to enter treatment were also examined.
RESULTS: Only 25 individuals (20.8%) entered treatment within four months of being placed on a waiting list. Intravenous drug users were more likely to enter treatment (p <.05) whereas cocaine users were less likely to do so (p <.01). Motivation did not predict treatment entry, and cocaine use did not moderate this relationship. There were some improvements in heroin use among those who did not enter treatment.
CONCLUSIONS: Additional research is needed on the relationship between motivation and treatment entry. Programs may need to make special efforts to facilitate entry for treatment-seeking heroin users who also use cocaine. SCIENTIFIC SIGNIFICANCE: These findings have implications for improving access to methadone treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19579092      PMCID: PMC2916645          DOI: 10.1080/00952990902968577

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  20 in total

1.  Predictive validity of a measure of treatment readiness for out-of-treatment drug users: enhancing prediction beyond demographic and drug history variables.

Authors:  James Alan Neff; William A Zule
Journal:  Am J Drug Alcohol Abuse       Date:  2002       Impact factor: 3.829

2.  Improving entry to methadone maintenance among out-of-treatment injection drug users.

Authors:  Robert E Booth; Karen F Corsi; Susan K Mikulich
Journal:  J Subst Abuse Treat       Date:  2003-06

3.  A randomized controlled trial of interim methadone maintenance: 10-Month follow-up.

Authors:  Robert P Schwartz; Jerome H Jaffe; David A Highfield; Jason M Callaman; Kevin E O'Grady
Journal:  Drug Alcohol Depend       Date:  2006-06-21       Impact factor: 4.492

4.  Predicting drug treatment entry among treatment-seeking individuals.

Authors:  Y I Hser; M Maglione; M L Polinsky; M D Anglin
Journal:  J Subst Abuse Treat       Date:  1998 May-Jun

5.  Facilitating treatment entry among out-of-treatment injection drug users.

Authors:  R E Booth; C Kwiatkowski; M Y Iguchi; F Pinto; D John
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

6.  Severity of heroin dependence and HIV risk. II. Sharing injecting equipment.

Authors:  M Gossop; P Griffiths; B Powis; J Strang
Journal:  AIDS Care       Date:  1993

7.  A randomized controlled trial of interim methadone maintenance.

Authors:  Robert P Schwartz; David A Highfield; Jerome H Jaffe; Joseph V Brady; Carol B Butler; Charles O Rouse; Jason M Callaman; Kevin E O'Grady; Robert J Battjes
Journal:  Arch Gen Psychiatry       Date:  2006-01

Review 8.  Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction.

Authors: 
Journal:  JAMA       Date:  1998-12-09       Impact factor: 56.272

9.  Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations.

Authors:  Peter D Friedmann; Stephenie C Lemon; Michael D Stein; Thomas A D'Aunno
Journal:  Health Serv Res       Date:  2003-06       Impact factor: 3.402

Review 10.  Heroin overdose: research and evidence-based intervention.

Authors:  Shane Darke; Wayne Hall
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

View more
  8 in total

1.  Interim treatment: Bridging delays to opioid treatment access.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2015-04-30       Impact factor: 4.018

2.  Dropout from interim methadone and subsequent comprehensive methadone maintenance.

Authors:  Jan Gryczysnki; Robert Schwartz; Kevin O'Grady; Jerome Jaffe
Journal:  Am J Drug Alcohol Abuse       Date:  2009-12-15       Impact factor: 3.829

3.  A business case for quality improvement in addiction treatment: evidence from the NIATx collaborative.

Authors:  Andrew R Quanbeck; Lynn Madden; Eldon Edmundson; James H Ford; K John McConnell; Dennis McCarty; David H Gustafson
Journal:  J Behav Health Serv Res       Date:  2012-01       Impact factor: 1.505

4.  Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?

Authors:  Lynn E Taylor; Michaela A Maynard; Peter D Friedmann; Cynthia J Macleod; Josiah D Rich; Timothy P Flanigan; Diana L Sylvestre
Journal:  J Addict Med       Date:  2012-09       Impact factor: 3.702

5.  Patterns in admission delays to outpatient methadone treatment in the United States.

Authors:  Jan Gryczynski; Robert P Schwartz; David S Salkever; Shannon Gwin Mitchell; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2011-08-06

6.  Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system.

Authors:  Jan Gryczynski; Jerome H Jaffe; Robert P Schwartz; Kristi A Dušek; Nishan Gugsa; Cristin L Monroe; Kevin E O'Grady; Yngvild K Olsen; Shannon Gwin Mitchell
Journal:  Am J Addict       Date:  2013 May-Jun

7.  Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.

Authors:  Stacey C Sigmon; Andrew C Meyer; Bryce Hruska; Taylor Ochalek; Gail Rose; Gary J Badger; John R Brooklyn; Sarah H Heil; Stephen T Higgins; Brent A Moore; Robert P Schwartz
Journal:  Addict Behav       Date:  2015-07-29       Impact factor: 3.913

8.  Within-subject evaluation of interim buprenorphine treatment during waitlist delays.

Authors:  Tatum N Oleskowicz; Taylor A Ochalek; Kelly R Peck; Gary J Badger; Stacey C Sigmon
Journal:  Drug Alcohol Depend       Date:  2021-01-20       Impact factor: 4.492

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.